168 THIRD AVENUE, WALTHAM, MA
Other Events, Press Release
News, Underwriting Agreement, Securities Holder Rights or Indentures, Legal Opinion
Reports Fourth Quarter and Full Year 2025 Results
Executive Departures - Michel Lagarde and Frederick M. Lowery Leave Company
Thermo Fisher Scientific Issues €1.1 Billion in Senior Notes
To Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
Reports Third Quarter 2025 Results
FY 2024
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Certificate
Registration of Securities
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Free Writing Prospectus
Specialized Disclosure Report
Submission Upload
Correspondence
Amended Notice of Proposed Sale of Securities